Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
No Form 4 activity for LABT in the last 90 days.
1 Form 4 filing on record, the earliest from May 6, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joseph Edward Tucker | Grant or award | Warrant to acquire Common Stock | 33,784 | $0.00 | - |
Lakewood-Amedex Biotherapeutics Inc. (LABT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-06. The full record for LABT runs to 1 Form 4 filing, the earliest from 2026-05-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of LABT were filed in the last 90 days.
No insider sales of LABT were filed in the last 90 days.
This page tracks LABT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add LABT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.